SE7801268L - Forfarande for framstellning av ett immunsuppressivt medel - Google Patents

Forfarande for framstellning av ett immunsuppressivt medel

Info

Publication number
SE7801268L
SE7801268L SE7801268A SE7801268A SE7801268L SE 7801268 L SE7801268 L SE 7801268L SE 7801268 A SE7801268 A SE 7801268A SE 7801268 A SE7801268 A SE 7801268A SE 7801268 L SE7801268 L SE 7801268L
Authority
SE
Sweden
Prior art keywords
procedure
production
immunsuppressive
agent
immunsuppressive agent
Prior art date
Application number
SE7801268A
Other languages
English (en)
Other versions
SE464616B (sv
Inventor
Sok
Original Assignee
Katz David Harvey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katz David Harvey filed Critical Katz David Harvey
Publication of SE7801268L publication Critical patent/SE7801268L/sv
Publication of SE464616B publication Critical patent/SE464616B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S524/90—Antigen-antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7801268A 1977-02-03 1978-02-02 Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen SE464616B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/764,586 US4191668A (en) 1977-02-03 1977-02-03 Induction of immunological tolerance

Publications (2)

Publication Number Publication Date
SE7801268L true SE7801268L (sv) 1978-08-04
SE464616B SE464616B (sv) 1991-05-27

Family

ID=25071153

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7801268A SE464616B (sv) 1977-02-03 1978-02-02 Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen

Country Status (17)

Country Link
US (1) US4191668A (sv)
JP (1) JPS53121943A (sv)
AU (1) AU515181B2 (sv)
BE (1) BE863656A (sv)
CA (1) CA1118347A (sv)
CH (1) CH644521A5 (sv)
DE (1) DE2804457C2 (sv)
DK (1) DK155174C (sv)
FI (1) FI780312A (sv)
FR (1) FR2379287A1 (sv)
GB (1) GB1599454A (sv)
LU (1) LU78997A1 (sv)
MX (1) MX6266E (sv)
NL (1) NL7801220A (sv)
NO (1) NO153419C (sv)
SE (1) SE464616B (sv)
ZA (1) ZA78613B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4276206A (en) * 1979-01-18 1981-06-30 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4253995A (en) * 1980-02-11 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
US4253996A (en) * 1980-02-13 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
DE3114362C2 (de) * 1980-04-11 1983-08-18 Toshiyuki Prof. Nara Hamaoka Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung
EP0077158A1 (en) * 1981-10-09 1983-04-20 Beecham Group Plc Modified allergens
US6022544A (en) * 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US4950713A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals
US5017648A (en) * 1986-05-30 1991-05-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US4950469A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
CA1309558C (en) * 1986-05-30 1992-10-27 Quidel D-gl conjugate therapy
US5552391A (en) * 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US5391785A (en) * 1990-01-16 1995-02-21 La Jolla Pharmaceutial Company Intermediates for providing functional groups on the 5' end of oligonucleotides
US5162515A (en) * 1990-01-16 1992-11-10 La Jolla Pharmaceutical Company Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
WO1993002093A1 (en) * 1991-07-15 1993-02-04 La Jolla Pharmaceutical Company Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US8071737B2 (en) 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
US5874409A (en) 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6399578B1 (en) * 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US20030044420A1 (en) * 1999-09-24 2003-03-06 Mccormick Alison A. Self antigen vaccines for treating B cell lymphomas and other cancers
US7084256B2 (en) * 1999-09-24 2006-08-01 Large Scale Biology Corporation Self antigen vaccines for treating B cell lymphomas and other cancers
AU2001268228A1 (en) 2000-06-08 2001-12-17 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825525A (en) * 1969-08-06 1974-07-23 Beecham Group Ltd Allergens reacted with carbodiimides
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation

Also Published As

Publication number Publication date
NO153419C (no) 1986-03-19
NO153419B (no) 1985-12-09
ZA78613B (en) 1978-12-27
FR2379287B1 (sv) 1980-08-29
DK155174C (da) 1989-07-10
DK155174B (da) 1989-02-27
LU78997A1 (fr) 1978-06-21
NO780366L (no) 1978-08-04
JPS53121943A (en) 1978-10-24
FR2379287A1 (fr) 1978-09-01
AU515181B2 (en) 1981-03-19
GB1599454A (en) 1981-10-07
MX6266E (es) 1985-02-27
CA1118347A (en) 1982-02-16
DE2804457A1 (de) 1978-08-10
JPH0428689B2 (sv) 1992-05-15
SE464616B (sv) 1991-05-27
NL7801220A (nl) 1978-08-07
DK49178A (da) 1978-08-04
CH644521A5 (de) 1984-08-15
DE2804457C2 (de) 1984-04-12
US4191668A (en) 1980-03-04
BE863656A (fr) 1978-05-29
AU3293378A (en) 1979-08-09
FI780312A (fi) 1978-08-04

Similar Documents

Publication Publication Date Title
SE7801268L (sv) Forfarande for framstellning av ett immunsuppressivt medel
FI782756A (fi) Anordning och foerfarande foer vaermebehandling av organiska kolhaltiga aemnen
NO158616C (no) Fremgangsmaate for fremstilling av ammoniakk.
FI780134A (fi) Foerfarande foer framstaellning av medel foer papperslimning
SE7811195L (sv) Forfarande for framstellning av mjuka samplyamider
DK354678A (da) Fremgangsmaade til fremstilling af propenylaminer
SE7800496L (sv) Forfarande for framstellning av titankarbid
NO781642L (no) Fremgangsmaate for fremstilling av flegmatisert sprengstoff
FI782434A (fi) Anordning foer smaeltning och raffinering av raokoppar
FI781938A (fi) Foerfarande och anordning foer framstaellning av goerdeldaeckvaevnad
DK452578A (da) Fremgangsmaade til fremstilling af furanderivater
NO781643L (no) Fremgangsmaate for fremstilling av flegmatisert sprengstoff
FI781357A (fi) Foerfarande och anordning foer framstaellning av polyuretanskum
SE7703628L (sv) Forfarande for framstellning av resoler
NO144886C (no) Fremgangsmaate til fremstilling av oksiranforbindelser
FI782574A (fi) Foerfarande foer framstaellning av n-substituerade 2-hydrazonopropionsyraderivat
NO782447L (no) Fremgangsmaate ved fremstilling av bis(nitrosoureido)-polyolderivater
SE7804208L (sv) Nytt forfarande for framstellning av auranofin
SE7505807L (sv) Forfarande for framstellning av ett antibakteriellt medel
SE7802324L (sv) Forfarande for framstellning av fosfor
NO153169C (no) Fremgangsmaate for fremstilling av ammoniakk.
SE7801536L (sv) Forfarande for framstellning av natriumperkarbonat
SE7805497L (sv) Forfarande for framstellning av urandioxidpulver
FI783434A (fi) Foerfarande och anordning foer uppskumning av ett flytande bindemedel
SE7804207L (sv) Nytt forfarande for framstellning av auranofin